European Pharmaceutical Price Regulation, Firm Profitability, and R&D Spending
Year of publication: |
November 2006
|
---|---|
Authors: | Golec, Joseph H. |
Other Persons: | Vernon, John A. (contributor) |
Institutions: | National Bureau of Economic Research (contributor) |
Publisher: |
Cambridge, Mass : National Bureau of Economic Research |
Subject: | EU-Staaten | EU countries | Regulierung | Regulation | Pharmaindustrie | Pharmaceutical industry | Arzneimittel | Pharmaceuticals | Preisregulierung | Price regulation | Rentabilität | Profitability | Europa | Europe | Arzneimittelmarkt | Pharmaceutical market | Preismanagement | Pricing strategy |
Extent: | 1 Online-Ressource |
---|---|
Series: | NBER working paper series ; no. w12676 |
Type of publication: | Book / Working Paper |
Language: | English |
Notes: | Mode of access: World Wide Web System requirements: Adobe [Acrobat] Reader required for PDF files Hardcopy version available to institutional subscribers. |
Other identifiers: | 10.3386/w12676 [DOI] |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Pharmaceutical Pricing in Europe : Is Differential Pricing a Win-Win Solution?
Garau, Martina, (2015)
-
Vogler, Sabine, (2019)
-
A ban on "private label" generic pharmaceuticals : legal and economic context
Anis, Aslam H., (2015)
- More ...
-
Financial Risk in the Biotechnology Industry
Golec, Joseph H., (2007)
-
Pharmaceutical price regulation : public perceptions, economic realities, and empirical evidence
Vernon, John A., (2008)
-
An exploratory study of FDA new drug review times, Prescription Drug User Fee Acts, and R&D spending
Vernon, John A., (2009)
- More ...